Skip to main content

Devices and technology: Flash glucose monitoring

medwireNews

05-04-2023 | Flash glucose monitoring | News

Reduced acute complications for young people using CGM

Data from the DPV cohort show a reduced risk for severe hypoglycemia and diabetic ketoacidosis among children and young people with type 1 diabetes using continuous glucose monitoring rather than self-monitored blood glucose.

07-03-2023 | Flash glucose monitoring | News

Flash glucose monitoring linked to type 2 diabetes treatment intensification

Use of intermittently scanned continuous glucose monitoring is associated with an increased likelihood for treatment intensification in people with type 2 diabetes, a study shows.

01-03-2023 | Flash glucose monitoring | News

One-off pre-consultation isCGM use helpful in type 2 diabetes

A short period of intermittently scanned continuous glucose monitoring prior to a first endocrinologist consultation can improve glycemic outcomes for people with type 2 diabetes, report the SPOT FIRST study researchers.

28-02-2023 | Flash glucose monitoring | News

Real-world isCGM benefits shown for people with psychosocial diabetes issues

People with high diabetes distress achieve reductions in glycated hemoglobin and the need for emergency care for acute diabetes complications after starting on intermittently scanned continuous glucose monitoring, report researchers.

15-02-2023 | Flash glucose monitoring | News

ALERTT1: rtCGM alarm benefits persist in long term

The benefits of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes are sustained for at least 2 years, shows the extension of the ALERTT1 study.

Close up oF device for continuous glucose monitoring in blood – CGM

15-12-2022 | Continuous glucose monitoring | News

Eliminating CGM cost barriers reduces disparities in use

Fully subsidizing continuous glucose monitors could overcome disparities in their use by people with diabetes, suggests research conducted in adults enrolled in a US Medicaid program.

21-09-2022 | EASD 2022 | Conference coverage | News

isCGM benefits sustained for at least 2 years

The improved glycemic control gained from use of intermittently scanned continuous glucose monitoring is sustained for at least 2 years in people with type 1 diabetes, show real-world data.

Girl with CGM

21-09-2022 | EASD 2022 | Conference coverage | News

Skin reactions rarely lead to diabetes device discontinuation

Skin reactions to glucose monitors and insulin pumps occur in more than a quarter of users but only occasionally result in device discontinuation, research shows.

21-09-2022 | EASD 2022 | Conference coverage | News

Libre upgrade illustrates power of hypoglycemia alerts

Gaining the use of a low blood glucose alert by switching from the FreeStyle Libre 1 to 2 reduces the amount of time people with type 1 diabetes spend in hypoglycemia, report researchers.

20-09-2022 | EASD 2022 | Conference coverage | News

Freestyle Libre cuts acute complication risk in insulin-treated type 2 diabetes

People taking basal insulin to treat type 2 diabetes experience a significant reduction in the risk for acute complications, which is sustained for at least 2 years after initiating use of the Freestyle Libre, say French researchers.

01-07-2022 | Flash glucose monitoring | News

Flash monitoring initiation may boost mental health

An observational study suggests that initiating flash glucose monitoring might lead to a reduction in symptoms of depression in people with insulin-treated diabetes.

06-06-2022 | ADA 2022 | Conference coverage | News

Increased time in range using FreeStyle Libre improves multiple diabetes outcomes

People with diabetes who spend longer with their blood glucose levels within target range have better glycated hemoglobin levels, reduced diabetes-related distress, better hypoglycemia awareness, and fewer hypoglycemia-related hospital admissions than individuals with diabetes that is less well controlled.

29-04-2022 | ATTD 2022 | Conference coverage | News

Most sensor-detected hypoglycemia goes unnoticed by people with diabetes

Early findings from the Hypo-METRICS trial indicate that people with diabetes are unaware on most of the occasions that their blood glucose dips into the hypoglycemic range.

31-03-2022 | DUKPC 2022 | Conference coverage | News

Flash UK: isCGM benefits hold up in setting of poor glycemic control

People with type 1 diabetes and poor glycemic control benefit from use of intermittently scanned continuous glucose monitoring versus self-monitored blood glucose, report the Flash UK investigators.

10-01-2022 | COVID-19 | News

COVID-19 vaccination may lead to temporary changes in glucose control

The proportion of on-target interstitial glucose values falls during the week following initial COVID-19 vaccination in people with type 1 diabetes, study findings indicate.

14-10-2021 | Flash glucose monitoring | News

Real-world data highlight universal benefits of flash glucose monitoring

Flash glucose monitoring improves glycemic control and reduces diabetic ketoacidosis rates across nearly all age, sex, and sociodemographic strata, regardless of insulin pump use, according to UK observational data.

28-09-2021 | EASD 2021 | Conference coverage | News

Poor hypoglycemia awareness ‘highly prevalent’ in children, young people with type 1 diabetes

Impaired hypoglycemia awareness is present in a substantial proportion of children and young people with type 1 diabetes and is associated with an increased risk for severe hypoglycemia, suggests research presented at the virtual 57th EASD Annual Meeting.

07-06-2021 | ATTD 2021 | Conference coverage | News

Better glycemic control with isCGM may lead to less diabetes distress

Gaining greater control of blood glucose and hypoglycemia awareness is associated with a reduction in diabetes distress among people who start using the FreeStyle Libre, researchers report.

Flash glucose monitoring

02-06-2021 | ATTD 2021 | Conference coverage | News

ALERTT1: Time in range, hypoglycemia worry improve with isCGM to rtCGM switch

Switching from intermittently scanned to real-time continuous glucose monitoring improves time in range by a clinically relevant percentage, show the findings of the 6-month ALERTT1 trial.

AdobeStock_318180238

07-04-2021 | Flash glucose monitoring | News

Real-world data support benefits of flash glucose monitoring

Flash glucose monitoring is associated with small but sustained improvements in glycemic control and a reduction in severe hypoglycemia relative to self-monitoring of blood glucose in type 1 diabetes, observational data show.